
Andrey Doronichev discusses the impact of AI on biotech research and drug discovery.
In this episode, Kristian Marquez welcomes Andrey Doronichev, founder of BIOPTIC and former Director of Product Management at Google. Andrey shares how his experience scaling YouTube to a billion users informed his transition into the biotech sector. We explore how AI is automating competitive intelligence in pharma, the lessons learned from Google’s Stadia project, and why the next decade of drug discovery belongs to AI-native companies. Learn more about Optic work at: https://bioptic.io/ Connect with Andrey Doronichev on LinkedIn at: https://www.linkedin.com/in/doronichev/ Think you'd be a great guest on the show? Apply at https://finstratmgmt.com/innovators-investors-podcast/ Want to learn more about Kristian Marquez's work? https://finstratmgmt.com
Explore listener stats, chart rankings, contacts and more on the The Innovators & Investors Podcast podcast page.